InsiderTrades

Form 4 for LNAI Lunai Bioworks Inc.

Accepted 2023-02-06 00:00:00 ET · period of report 2018-02-16 · accession 0001214659-23-001671 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2023-02-06 2018-02-16+ LNAI Weird Science LLC 10% J - Other — +1.31M 4.90M +37% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2018-02-16 J A 17,545,283 — 17,545,283 D — — (F1) The Reporting Person received these shares as merger consideration in exchange for the Reporting Person's common stock of Enochian BioPharma, Inc., which the Issuer acquired by merger on February 16, 2018. In addition to such shares, the Agreement and Plan of Merger governing the merger (the "Merger Agreement") provides that upon the exercise or conversion of options and warrants to purchase shares of the Issuer's common stock that were outstanding as of the closing of the merger, the Issuer will issue a like number of shares of Common Stock (referred to as "Earn-Out Stock") to the former stockholders of Enochian BioPharma, Inc., including the Reporting Person, on a pro rata basis. The Reporting Person's right to receive additional shares of the Issuer's common stock as Earn-Out Stock became fixed and irrevocable on February 16, 2018, the closing date of the merger.
2 Common Common Stock 2018-12-31 J A 1,268,880 — 18,814,163 D — — (F2) Shares were received by the Reporting Person as Earnout Stock pursuant to the Merger Agreement. The Reporting Person's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the date of the closing under the Merger Agreement.
3 Common Common Stock 2019-07-30 J A 3,631,234 — 22,445,397 D — — (F2) Shares were received by the Reporting Person as Earnout Stock pursuant to the Merger Agreement. The Reporting Person's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the date of the closing under the Merger Agreement.
4 Common Common Stock 2022-10-13 J A 1,216,467 — 1,313,499 D — — (F2) Shares were received by the Reporting Person as Earnout Stock pursuant to the Merger Agreement. The Reporting Person's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the date of the closing under the Merger Agreement.
5 Common Common Stock 2020-12-14 J A 61,249 — 4,961,363 D — — (F2) Shares were received by the Reporting Person as Earnout Stock pursuant to the Merger Agreement. The Reporting Person's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the date of the closing under the Merger Agreement.
6 Common Common Stock 2022-04-11 J A 97,032 — 5,058,395 D — — (F2) Shares were received by the Reporting Person as Earnout Stock pursuant to the Merger Agreement. The Reporting Person's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the date of the closing under the Merger Agreement.
7 Common Common Stock 2022-04-15 J D 4,961,363 — 97,032 D — — (F3) Pro rata distribution to the members of the Reporting Person.
8 Common Common Stock 2020-05-29 J D 17,545,283 — 4,900,114 D — — (F3) Pro rata distribution to the members of the Reporting Person.